Eloise sells AGN 159.37: Allergan Reiterates its Belief that Valeant's Business Model is Unsustainable
Re-Revised Proposal Creates Significant Risks and Uncertainties for Allergan Stockholders Numerous Third Parties Agree Allergan, Inc. (NYSE: AGN) ("Allergan" or the "Company") today reiterated the Company's concern regarding Valeant Pharmaceuticals ... ...
60 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home